97 results
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
25 Apr 24
Additional proxy soliciting materials
4:02pm
year ending December 31, 2024.
For
Proposal to approve, on an advisory basis, executive compensation.
For
Non-binding shareholder proposal
8-K/A
REGN
Regeneron Pharmaceuticals, Inc.
8 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
advisory shareholder votes on executive compensation. No changes have been made to the Original Report.
Item 5.07.
Submission of Matters to a Vote … , on a proposal on the frequency of future advisory shareholder votes on executive compensation. As reported by the Company in the Original Report
8-K
vrjpewsc nof
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
DEFA14A
mirjp0rv385e7kw9l
21 Apr 23
Additional proxy soliciting materials
4:03pm
8-K
q2q8o1p3
15 Jun 22
Submission of Matters to a Vote of Security Holders
4:11pm
DEFA14A
ycwk2olq
21 Apr 22
Additional proxy soliciting materials
4:21pm
DEFA14A
hgk tsmxn
21 Apr 22
Additional proxy soliciting materials
4:15pm
CORRESP
tfshi
7 Dec 20
Correspondence with SEC
12:00am